AMZN
Amazon.com, Inc.
AMZN has the edge over CHPT overall, supported by lower modeled downside and stronger valuation.
CHPT
ChargePoint Holdings, Inc.
CHPT offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CHPT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
CHPT's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
CHPT PE Valuation
CHPT has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CHPT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CHPT's losses to shrink, with revenue growing.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CHPT on earnings quality, reporting a profit while its opponent remains loss making.
CHPT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$7.26 | +$4.19 |
| Q2 2026 | -$8.76 | +$3.04 |
| Q1 2026 | -$9.41 | +$3.39 |
| Q4 2025 | -$10.08 | +$4.32 |
| Q3 2025 | -$11.45 | +$7.95 |
| Q2 2025 | -$11.80 | +$11.40 |
| Q1 2025 | -$12.80 | +$11.60 |
| Q4 2024 | -$14.40 | +$10.20 |
CHPT is still losing money, but far less than before: $7.26 per share over the past year, against $29.80 at its worst in early 2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CHPT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CHPT on profitability, with a higher operating margin.
CHPT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $116.1M | +18% |
| Q2 2026 | $101.8M | +4.3% |
| Q1 2026 | $109.3M | +7.3% |
| Q4 2025 | $105.7M | +6.1% |
| Q3 2025 | $98.6M | -9.2% |
| Q2 2025 | $97.6M | -8.8% |
| Q1 2025 | $101.9M | -12% |
| Q4 2024 | $99.6M | -9.7% |
CHPT's revenue is recovering but still below its 2023 peak: $116M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -29% | +31 points |
| Q2 2026 | -46% | +8.8 points |
| Q1 2026 | -48% | +5.5 points |
| Q4 2025 | -42% | +27 points |
| Q3 2025 | -60% | -2 points |
| Q2 2025 | -55% | +7.6 points |
| Q1 2025 | -54% | +26 points |
| Q4 2024 | -68% | +71 points |
CHPT's operating margin was −29% last quarter, up 30 points from the same quarter a year ago, near the top of its range since 2019.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CHPT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.2M | +$2.3M |
| Q2 2026 | -$37.7M | -$3.7M |
| Q1 2026 | -$2M | +$2.6M |
| Q4 2025 | -$23.6M | +$9.8M |
| Q3 2025 | -$7.5M | +$47.5M |
| Q2 2025 | -$34M | +$32M |
| Q1 2025 | -$4.6M | +$41.6M |
| Q4 2024 | -$33.4M | +$68.3M |
CHPT has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over CHPT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CHPT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.9% | +1.7M shares |
| 1 year | +13% | +3.1M shares |
| 3 years | +48% | +8.5M shares |
| 5 years | +68% | +10.6M shares |
CHPT has 26M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CHPT Net Leverage
CHPT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CHPT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.1 | Neutral |
| Stochastic | 84.4 | Overbought |
CHPT's weekly RSI is 65 (neutral) and its Stochastic is 84 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
CHPT PE vs Consumer Cyclical Sector
CHPT has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CHPT on trend strength, trading above more of its moving averages.
CHPT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.32 | 29% above |
| 20 week MA | $7.81 | 54% above |
| 50 week MA | $7.08 | 70% above |
| 100 week MA | $10.4 | 16% above |
| 200 week MA | $49.3 | 76% below |
CHPT has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 76% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
CHPT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $196.0 | $922.0 | +370% |
| 2021 | $922.0 | $381.0 | -59% |
| 2022 | $381.0 | $171.0 | -55% |
| 2023 | $171.0 | $46.8 | -73% |
| 2024 | $46.8 | $22.8 | -51% |
| 2025 | $22.8 | $7.08 | -69% |
| 2026 YTD | $7.08 | $12.1 | +70% |
CHPT has the edge over AMZN on returns for 2026, with the stronger performance.